Viewing Study NCT02390869


Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-01-05 @ 5:21 PM
Study NCT ID: NCT02390869
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-02
First Post: 2015-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients
Sponsor: Fondazione Italiana Linfomi - ETS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module